Effects of Bronchodilator in Obstructive Airway Diseases
Author(s): Aparajeet Kar, Suryanarayana V, Krishnarajasekhar OR*
The present study was a prospective study to assess the severity of Obstructive Airway Disease in patients attending our outpatient department and to assess the Bronchodilator response in terms of change in FEV1 in such patients to a single dose of salbutamol nebulization. FEV 1% Post-bronchodilator changes is insignificant in patients suffering from Bronchial Asthma with older age group. FEV 1% Post-Bronchodilator changes is significant in patients suffering from COPD GOLD Stage I and II. No significant post-Bronchodilator FEV1% changes were seen in patients suffering from COPD GOLD stage III and IV. There were no significant Post-Bronchodilator FEV1% changes in patients suffering from Bronchiectasis, Post-TB OAD. The effect of Bronchodilator is not found to be useful in Bronchiectasis Salbutamol is a potent drug for treating patients with Bronchial Asthma and COPD stage I and II.